Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

560.70 +2.69 (+0.48%)

Streaming Delayed Price Updated: 11:27 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Madrigal Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock ↗

August 14, 2024

One player's minor pain is another's moderate gain.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2024

Via Benzinga

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains' ↗

August 07, 2024

Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations.

Via Investor's Business Daily

Topics Earnings

Is It Too Late to Buy Madrigal Pharmaceuticals Stock? ↗

August 05, 2024

Will being the first to its market ensure that its future is bright?

Via The Motley Fool

7 Biotech Stocks to Keep on Your Clinical Radar ↗

July 23, 2024

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.

Via InvestorPlace

Is Madrigal Pharmaceuticals Stock a Buy? ↗

May 21, 2024

It's not the most prominent biotech, but it has an important claim to fame.

Via The Motley Fool

2 Under-the-Radar Growth Stocks to Consider ↗

April 10, 2024

Don't ignore these innovative companies.

Via The Motley Fool

1 No-Brainer Growth Stock to Buy Now ↗

April 03, 2024

This liver-disease specialist might be significantly undervalued.

Via The Motley Fool

Is Madrigal Pharmaceuticals a Millionaire Maker? ↗

June 30, 2024

Its revenue ramp-up is just starting, and its market looks lucrative.

Via The Motley Fool

Is Madrigal Pharmaceuticals Stock a Buy? ↗

June 28, 2024

The company could become a prominent player in the biotech industry, but that might take a while.

Via The Motley Fool

The Best Biotech Stock to Invest $1,000 in Right Now ↗

June 18, 2024

This stock may not be a slam dunk, but it's looking very promising.

Via The Motley Fool

Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender ↗

June 17, 2024

The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment.

Via Investor's Business Daily

Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word. ↗

June 16, 2024

Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.

Via The Motley Fool

Where Will Madrigal Pharmaceuticals Be in 3 Years? ↗

June 15, 2024

The coast is clear for it to grow, for now.

Via The Motley Fool

Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade ↗

June 12, 2024

On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 11, 2024

Via Benzinga

Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals ↗

June 10, 2024

Success isn't guaranteed, but both companies could become big winners.

Via The Motley Fool

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? ↗

June 05, 2024

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment....

Via Benzinga

Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH ↗

June 05, 2024

Researchers published results Wednesday showing Lilly's weight-loss drug could work in a liver disease.

Via Investor's Business Daily

DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug ↗

June 04, 2024

Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

Via Investor's Business Daily

The Week Ahead: What's Next ↗

June 02, 2024

The core part of our portfolio is up 24% this year ... and we're about to add another stock. Plus, a riddle.

Via Talk Markets

MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024 ↗

May 07, 2024

MDGL stock results show that Madrigal Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 07, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

6 Stocks Positioned to Soar as Investors Focus on MASH

April 22, 2024

Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of...

Via TheNewswire.com

7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024 ↗

April 15, 2024

Analyst-backed stocks have a high correlation with future stock price growth. Here are seven stocks with a high number of recent upgrades.

Via InvestorPlace

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics ↗

April 05, 2024

These businesses should see good times ahead.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in April 2024 ↗

April 01, 2024

Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.

Via InvestorPlace

2 Top Biotech Buyout Candidates ↗

March 31, 2024

Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.